C07C 239/02
Compounds containing nitrogen-to-halogen bonds
C07C239/02 (Compounds containing nitrogen-to-halogen bonds) appears on 23 US grants and 8 published applications in this corpus.
Search patents in C07C- Granted patents
- 23
- Published applications
- 8
- Assignees
- 19
- Inventors
- 64
- Latest grant
- 9 Mar 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 3 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 2 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 2 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 1 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Compounds and methods for treatment and prevention of Flavivirus infection9 Mar 2021US 10,940,188 B2The Florida State University Research Foundation, Inc.
- Process for preparing Brivaracetam22 Sep 2020US 10,781,170 B1Divi’s Laboratories Ltd.
- Process for preparing chloroamines9 Aug 2016US 9,409,863 B2Bayer Intellectual Property GmbH
- Substituted N,N-dihaloamines as antimicrobials2 Feb 2016US 9,248,117 B2NovaBay Pharmaceuticals, Inc.
- Adamantane derivatives possessing anti-viral and anti-microbial activity16 Sep 2014US 8,835,507 B2Vymed Corporation
- Compounds and methods for treatment and prevention of flavivirus infection28 May 2020US 2020/0164051 A1The Florida State University Research Foundation, Inc.
- Compounds and methods for treatment and prevention of flavivirus infection18 Jan 2018US 2018/0015153 A1
- Process for preparing chloroamines22 Jan 2015US 2015/0025245 A1Bayer Intellectual Property GmbH
- Adamantane derivatives possessing anti-viral and anti-microbial activity5 Sep 2013US 2013/0231391 A1Vymed Corporation
- Antimicrobial Polyether and Polyol Compounds24 May 2012US 2012/0129793 A1NovaBay Pharmaceuticals, Inc.
Most cited
By later US patents
- Synthetic techniques and intermediates for polyhydroxy, dienyl lactones and mimics thereof13US 5,789,605 AThe Trustees of the University of Pennsylvania · 1998
- Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives12US 6,096,904 AThe Trustees of the University of Pennsylvania · 2000
- Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives9US 6,242,616 B1The Trustees of the University of Pennsylvania · 2001
- N,N-dihalogenated amino acids and derivatives5US 7,893,109 B2NovaBay Pharmaceuticals, Inc. · 2011
- Derivatives of N-chloro-N-methyl glucamine and N-chloro-N-methyl glucamine esters4US 5,985,239 AUniversity of Kentucky Research Foundation · 1999